Erratum: First‐in‐class pyrido[2, 3‐d]pyrimidine‐2, 4(1H, 3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights. Issue 4 (1st March 2022) - Ramesh, Deepthi; Sarkar, Deblina; Joji, Annu; Singh, Monica; Mohanty, Amaresh K.; Vijayakumar, Balaji G.; Chatterjee, Mitali; Sriram, Dharmarajan; Muthuvel, Suresh K.; Kannan, Tharanikkarasu